Volvo plans to sell only electric cars by 2030 and become a climate-neutral company a decade later. It represents one of the most fundamental shifts for a legacy automaker, with an intermediate step: eliminating its internal combustion engine offerings.
Now, Volvo has set a date for excluding diesel cars from its sales. So, at New York Climate Week announced that its last car with such an engine will be produced in early 2024. Currently, many models of the Swedish brand are still equipped with this engine, such as the XC60, V60, XC90, V90 and S90. The cars are powered by a 2-liter micro-hybrid engine with a 48-volt electrical architecture, with the 197-horsepower version designated B4 and the 235-horsepower version designated B5. Until four years ago, most of the products sold by Volvo had this type of engine.
Since Volvo sold its stake in Aurobay in November 2022, the company has no longer invested any of its R&D budget in the development of new internal combustion engines.. Jim Rowan, CEO of Volvo Cars, said: “Electric powertrains are our future and are better than internal combustion engines: they produce less noise, less vibration, lower customer service costs and have tailpipe emissions of Zero.” “We are fully focused on building a broad portfolio of high-quality all-electric vehicles that deliver everything customers have come to expect from Volvo and are a key part of our fight against climate change.”
As a result, Volvo is focusing on electrification, driven by emissions regulations and changing demandturning around its sales and ensuring that the majority of cars currently reaching customers have electric or plug-in hybrid propulsion systems.
Reducing diesel on the streets also has a positive impact on urban air quality; therefore, although diesel engines emit less carbon dioxide than gasoline engines, they contain more compounds such as nitrogen oxides (NOx). These gases, the products of high-temperature combustion with oxygen-rich mixtures, are harmful to health because they can cause reduced lung capacity, bronchitis, asthma, allergies, and mucous membrane or eye irritation.